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ABSTRACT
Objective: To evaluate the association between MetS, its components and insulin resistance (IR) 
with 25(OH)D and hsCRP. The moderator role of 25(OH)D in the association of MetS, its diagnostic 
components and IR with hsCRP were also explored. Materials and methods: A cross-sectional study 
(2014/2015) with a population-based cohort in Southern Brazil (n = 605). Metabolic syndrome (MetS) 
diagnosis was defined based on the Joint Interim Statement, while the Homeostasis Model Assessment 
of insulin resistance (IR) (HOMA-IR) was used for determining IR. Serum concentrations of 25-hydroxy 
vitamin D [25(OH)D] (ng/mL) and high sensitivity C-reactive protein (hsCRP) (mg/L) were evaluated 
following standard protocols. 25(OH)D was categorized as sufficiency (>30 ng/mL), insufficiency (20-
30 ng/mL) or deficiency (<20 ng/mL) to test its moderator role. Multiple linear regression was used to 
test the associations. The results were adjusted for possible confounders. Results and discussion: 
Hypertriglyceridemia and IR were associated with lower 25(OH)D concentrations. However, except 
for systolic blood pressure, other MetS components and IR were associated with higher hsCRP. The 
association between elevated waist circumference (WC) and hsCRP was moderated by the 25(OH)
D concentrations. The hsCRP median concentrations were more than two times higher among those 
with elevated WC and 25(OH)D insufficiency or deficiency. In this study, inadequate concentrations 
of 25(OH)D increased the adverse relationship between elevated WC and inflammation. 25(OH)
D concentrations could be incorporated into the clinical protocols for monitoring individuals with 
abdominal obesity to identify those at a higher risk of complications. Arch Endocrinol Metab. 2020;64(6):695-703
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INTRODUCTION
Metabolic syndrome (MetS) is a condition that combines several cardiometabolic risk 
factors, including abdominal obesity, hypertension, 
dyslipidemia, hyperglycemia and insulin resistance 
(IR). MetS is associated with the development of 
diabetes mellitus, cardiovascular disease (CVD) and 
their complications, including hospitalizations and 
deaths (1).
MetS is characterized by the release of free fatty 
acids, which promote chain reactions in different 
tissues, modifying glycemic markers, lipoproteins, 
blood pressure concentrations and IR (1). These 
metabolic abnormalities are associated with chronic 
inflammation of low intensity, including increased 
synthesis of C-reactive protein (CRP), which is a marker 
of cardiovascular risk (2).
In parallel, hypovitaminosis D has also been 
associated with systemic inflammation and MetS (3-5). 
The Framingham Offspring Study conducted a study 
between 1997-2001 to corroborate data provided by in 
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(25(OH)D) on inflammatory markers, but found a 
null association between concentrations of this vitamin 
and high-sensitivity CRP (hsCRP) concentrations (3). 
Nonetheless, an Australian study including healthy 
individuals found an inverse association between 
25(OH)D and hsCRP (4), while a German population-
based study involving individuals aged 25-88 verified a 
U-shaped relationship between these variables (5). In 
the German study, hsCRP was lower among those with 
a 25(OH)D concentration between 21-25 ng/mL, 
while higher values of hsCRP were observed when the 
concentrations of 25(OH)D were below 21 or above 
25 ng/mL (5). 
Moreover, an Iranian randomized controlled 
trial (RCT) found that vitamin D supplementation 
in diabetic adults with coronary artery disease and 
deficiency of vitamin D reduced glycemia and CRP 
(n = 60) (6). However, that association was not consistent 
in studies including overweight or obese adults (7). 
The possible moderator role of 25(OH)D in the 
association between MetS and IR with CRP has been 
barely explored in population-based samples from 
middle or low-income countries. This study is relevant 
considering the abrupt increase in the prevalence of 
obesity, diabetes, and other non-communicable diseases 
that these countries are facing (8). 
Therefore, this study was designed to investigate 
the association of MetS, its diagnostic components and 
IR with 25(OH)D and hsCRP concentrations by using 
a population-based cohort of adults in Southern Brazil. 
The moderator role of 25(OH)D in the association 
between MetS and hsCRP was also explored.
MATERIALS AND METHODS
Study design
This study constituted a cross-sectional analysis of 
the third wave of the EpiFloripa Adults Cohort Study 
(2014/15), a populational-based study started in 
2009 with a representative sample of adults, living in 
Florianópolis, capital of Santa Catarina State, Southern 
Brazil.
The random sampling process was used in the baseline 
recruited 1,720 individuals and was performed in two 
phases. Firstly, 63/420 census tracts (census units) were 
systematically selected in each decile of family income, 
and subsequently, 1,134/16,755 households were 
systematically selected in these sectors. All individuals 
between 20 and 59 years old were considered eligible, 
except those who had been amputated, bedridden, 
hospitalized, or affected by severe mental or physical 
health illnesses that could compromise anthropometric 
measurements, or the quality of the information 
obtained during the interviews.
The third wave of EpiFloripa Adults study was 
approved by the Ethics Committee on Human Research 
from State University of Santa Catarina (protocol 
nº 724.824; CAEE number 31020214.4.0000.0118). 
All participants signed an informed consent form.
Participants
The baseline of the EpiFloripa Adults Study (2009) 
intended to estimate the prevalence of several health 
outcomes by using face-to-face interviews at the 
household of the participants. The present study was 
conducted between August 2014 and June 2015, with 
all adults included in the baseline traced (third wave of 
the cohort, Figure 1) and having their anthropometric 
measurements and blood pressure assessed at the 
Laboratory of Anthropometry of the Federal University 
of Santa Catarina, where blood samples were also 
collected for laboratory tests. 
Of the 1,720 individuals included in the baseline, 
50.1% were located and interviewed in 2014/15. The 
final sample included for analysis (complete data for 
1st wave 2009-2010
1,720 adults
Follow-up losses (n = 498)
2st wave 2012-2013
1,222 adults (71.0%)
Follow-up losses (n = 392)
Individuals with full data 
for analysis
605 adults
Excluded (n = 257)
Pregnant (n = 1)
Recent infection (n = 100)
Incomplete data on exposure 
or outcomes (n = 156)
3st wave 2014-2015
862 adults (50.1%)
Sociodemographic data (n = 862)
Anthropometric data (n = 830)
Blood pressure data (n = 834)
Biochemical (n = 712)
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Blood samples were collected by peripheral 
venipuncture after 8-10 hours fasting and then 
stored, transported and analyzed following a standard 
protocol. Fasting serum glucose concentration 
was measured by adapting the hexokinase-glucose-
6-phosphate dehydrogenase method using the 
cartridge kit Flex® Reagent Cartridge GLUC and the 
autoanalyser Dimension® Clinical Chemistry System 
(Siemens Healthcare Diagnostics Inc. Newark, United 
States). Fasting serum insulin concentration was 
measured by the particle chemiluminescence method 
(Centauro®  Siemens Healthcare Diagnostics Inc., 
Newark, United States). 
Triglycerides serum concentration was measured 
by automated endpoint bichromatic colorimetric 
enzymatic method, using cartridge kits (Flex® Reagent 
Cartridge CHOL and TGL, Newark, United States). 
HDL-cholesterol serum concentration was measured 
by selective accelerator detergent method (Flex® 
Reagent Cartridge AHDL, Newark, United States). 
Finally, 25(OH)D serum concentration was 
measured by the Particle Chemiluminescence 
method (Centauro®  Siemens Healthcare 
Diagnostics Inc., Newark, United States), while 
hsCRP serum concentration was measured using 
immunonephelometry (BN II®, Siemens Healthcare 
Diagnostics Inc., Newark, United States). 
Definition of exposure and outcome variables
MetS diagnosis was based on the Joint Interim 
Statement JIS 2009 criterion (12). Individuals were 
considered positive for MetS when they presented at 
least three altered components of: 1) elevated WC 
(> 90 cm for men or > 80 cm for women); 2) high 
blood pressure (SBP ≥ 130 mm/Hg or DBP ≥ 85 
mm/Hg); 3) hyperglycemia (fasting blood glucose ≥ 
100 mg/dL); 4) elevated triglycerides (≥ 150 mg/dL), 
and; 5) reduced HDL-cholesterol (< 40 mg/dL in 
men or < 50 mg/dL in women). Regardless of the 
laboratory results, individuals who reported the use of 
some medication for controlling their blood pressure, 
glycemia, or lipid concentrations were considered as 
positive for high blood pressure, hyperglycemia or 
dyslipidemia, respectively.
To determining IR, the mathematical model 
Homeostasis Model Assessment of Insulin Resistance 
(HOMA-IR) was used (HOMA-IR = fasting glycemia 
(mmol/L) x fasting insulin (uU/mL)/22.5). The 
exposure and outcomes, excluding pregnant women 
(n = 1) and those with a recent infectious disease 
(n = 100) was 605 individuals. The power of the study 
was estimated a posteriori, considering an exposure 
prevalence of 35% (MetS) and the parameters of the 
outcomes [25(OH)D 24.7 ± 8.1 and hsCRPln 0.25 ± 
1.15]. Based on the available sample size, this study was 
able to detect mean differences of at least 2.8 ng/mL 
and 0.40 mg/L, respectively (alpha = 5%, power = 80%, 
design effect = 1.5). 
Data collection
A questionnaire was used in each cohort wave to collect 
data on sociodemographic characteristics, lifestyle (i.e. 
current smoking, physical activity level), self-reported 
conditions, medication use and other health variables. 
Physical activity was evaluated using a validated 
questionnaire from the Surveillance of Risk Factors and 
Protection for Chronic Diseases by Telephone Enquiry 
(Vigitel) (9).
Standardized techniques were used to measure 
weight (kg), height (m) and waist circumference (WC) 
(cm). Anthropometric measures were assessed twice 
and the mean of two measurements was used in the 
study. Weight was measured using portable digital 
scales (Marte® LC 200 pp, São Paulo, Brazil), with 150 
kg capacity and 100 g resolution. Height was measured 
using a stadiometer (Altura Exata®, Santa Efigênia, 
Brazil) with 1 mm resolution and 250 cm capacity. WC 
was measured using an inelastic anthropometric tape 
(Sanny®, São Bernardo do Campo, Brazil) with 1 mm 
resolution and 200 cm capacity. Data collection was 
performed after equipment calibration and interviewer 
training (including standardization of anthropometric 
measurements according to technical errors of 
measurement (TEM) intra- and inter-observer) (10).
Blood pressure was also measured twice using 
a digital wrist sphygmomanometer (Techline®, São 
Paulo, Brazil) and following the protocol of the 
Brazilian Society of Cardiology (11). A rest interval 
of at least 15 minutes before the first measurement 
and between measurements was considered. When 
the difference between measurements was greater 
than 20 mmHg for systolic blood pressure (SBP) or 
10 mmHg for diastolic blood pressure (DBP), a third 
blood pressure measurement was performed to replace 
the highest value. The mean of the two lowest blood 
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adopted cut-off point for the Brazilian population was 
a value above 2.7 (13).
Due to its non-normal distribution, hsCRP (in 
mg/L) was transformed into its natural logarithm 
(hsCRPln) and analyzed as a continuous variable. 
25(OH)D concentrations were analyzed as a 
continuous variable and additionally classified according 
to the Endocrine Society clinical practice guideline 
and Recommendations of the Brazilian Society of 
Endocrinology and Metabology (14,15) as sufficiency 
(> 30 ng/mL), insufficiency (20-30 ng/mL) or 
deficiency (< 20 ng/mL).
Confounding factors
These variables were selected based on the evidence of 
previous studies that have associated MetS, 25(OH)D 
deficiency and increased hsCRP with age, sex, education 
level, smoking, physical activity, solar radiation levels 
and body mass index (BMI, based on measured weight 
and height) (16). Physical activity level was evaluated by 
combining intensity, frequency and duration of leisure 
physical activity. Individuals were considered physically 
active when they reported moderate-intensity physical 
activity of 30 or more minutes at least five days/week 
or vigorous-intensity physical activities for at least 20 
minutes in three or more days/week (9). Solar radiation 
was defined based on the interview month (blood 
collection), as higher radiation levels for the Southern 
hemisphere occur between September and March, and 
lower levels from April to August.
Statistical analysis
Asymmetric continuous variables were presented 
as medians and interquartile range, and symmetric 
variables as mean and standard deviation. Categorical 
variables were presented as percentage (%).
The comparison of the sample characteristics 
between those with or without MetS was performed 
using the chi-square test for categorical variables and 
T-test for continuous variables.
Multiple linear regression was used to test the 
association between MetS, its diagnostic components 
and IR with the 25(OH)D and hsCRPln concentrations. 
These results were expressed as regression coefficients 
(β) with their respective 95% confidence interval 
(95% CI). Results for hsCRPln were presented in its 
exponential form (βexp) and interpreted as a risk ratio 
(times higher/lower hsCRP concentration among 
exposed compared to the geometric mean observed in 
non-exposed).
All analyses were adjusted for sex, age, education 
level, smoking, physical activity level and BMI. The 
solar radiation level was an additional confounder 
considered in adjusted analysis when the 25(OH)
D was investigated as the outcome. The variance 
inflation factor (VIF) was investigated as an indicator 
of over-adjustment and multicollinearity between the 
explanatory variables. 
The possible moderator role of 25(OH)D in 
the association of MetS, its diagnostic components 
and IR with hsCRP was investigated by introducing 
multiplicative terms between 25(OH)D status and 
hsCRP in the regression models. A p-value < 0.10 
for interaction was considered as suggestive of 
heterogeneity of the effects. In this case, results were 
presented graphically as the median and interquartile 
range of hsCRP (estimated based on quantile regression 
models and adjusted for confounders) among those 
with or without MetS/IR, stratified according to the 
25(OH)D concentrations (sufficiency, insufficiency or 
deficiency). 
All statistical analyses were performed in the 
STATA® 14.0 statistical software (Stata Corp., College 
Station, Texas, USA), considering the clusters and 
using sampling weights (probability of selection in the 
baseline and probability of being located in 2014/15).
RESULTS
The sample characteristics at baseline (2009) and their 
comparison with those included in the study (n = 605) 
or with MetS are described in Table 1. The proportion 
of males at baseline was slightly lower than females and 
77.4% had finished their primary education level (> 8 
years of education). Around 20% were current smokers, 
15% were physically active, and 39% had elevated WC. 
The distribution of these characteristics among those 
located in 2014/15 and included for analysis resembled 
the distribution of the original cohort (less than five 
percentage point difference for categorical variables and 
< 10% difference for the mean age). Among individuals 
with MetS (prevalence 35%, 95% CI 30.0-39.6), there 
was a higher proportion of males, older individuals, 
with a lower education level or elevated WC that their 
peers, but no difference was observed according to 
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Table 1. Sample characteristics in the baseline (2009) and comparison with those analyzeda in the study and those with metabolic syndrome (2014/15)
Variablesb
Baseline (2009) Third wave (2014/15)a







Gender (males) 44.5 42.5 49.9*
Age (years) 37.7 ± 11.6 39.6 ± 11.4 44.6 ± 10.7*
Education level
 0-8 years 22.7 20.5 28.7*
 9-11 years 33.6 30.3 26.8
 ≥12 years 43.8 49.3 44.5
Current smokers 19.4 15.4 17.5
Physically activec 15.4 15.8 13.0
Elevated waist circumferenced 39.4 43.8 75.5*
* P-value < 0.05 for the comparison between those analysed with or without metabolic syndrome.
a Including individuals located in 2014/15 with complete data for the exposure and outcome variables, but excluding pregnant women (n = 1) or those with a recent infectious disease (n = 100).
b Variables considering characteristics of the sample in the baseline (2009).
c ≥ 30 minutes of moderate-intensity physical activity in at least five days/week or ≥ 20 minutes of vigorous-intensity physical activity in three or more days/week (leisure physical activity).
d Waist circumference > 90.0 cm in males or > 80 cm in female.
Table 2 shows the prevalence of the MetS 
components and IR and its association with 25(OH)
D and hsCRPln concentrations. Elevated WC and high 
blood pressure were the most prevalent components of 
MetS, while 29.1% (95% CI 25.1-33.5) were positives 
for IR. The mean 25(OH)D in the sample was 24.7 ± 
8.1 ng/mL and was lower among those with MetS or 
IR. Among the MetS components, hypertriglyceridemia 
was the only variable associated with lower 25(OH)D 
concentrations. The median hsCRP was 1.34 mg/L 




βexp (95%CI) βexp (95%CIexp)
Metabolic syndromec 35.0 -0.75 (-2.30; 0.81) 1.46 (1.18; 1.81)**
Elevated WC 47.6 -0.41 (-1.86; 1.04) 2.01 (1.62; 2.51)***
Elevated SBP 50.8 -0.21 (-1.60; 1.18) 1.18 (0.99; 1.41)
Elevated DBP 46.1 -1.09 (-2.75; 0.58) 1.42 (1.17; 1.73)**
Elevated fasting glucose 17.2 -1.43 (-3.33; 0.46) 1.40 (1.10; 1.79)**
Elevated triglycerides 20.5 -3.12 (-4.88; -1.37)** 1.53 (1.20; 1.97)**
Low HDL 36.2 -0.43 (-1.77; 0.90) 1.54 (1.23; 1.93)***
Insulin resistanced 29.1 -2.00 (-3.58; -0.41)* 1.75 (1.41; 2.17)***
β = regression coefficient representing the mean difference in 25(OH)D concentrations between exposed and non-exposed.
β
exp
 = regression coefficient in exponential form, interpreted as a risk ratio (times higher/lower hsCRP concentration among exposed compared to the geometric mean among non-exposed).
P-value: * < 0.05; ** < 0.01; *** < 0.001.
CI: confidence interval; 25(OH)D: 25-hydroxyvitamin D; hsCRP
ln
: natural logarithm of the high-sensitivity C-reactive protein; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic 
blood pressure; HDL: high-density lipoproteins.
a Mean 25(OH)D 24.7 ± 8.1 ng/mL. Results adjusted for gender, age, education level, physical activity level, smoking, solar radiation level and body mass index.
b Median hsCRP 1.34 mg/L (interquartile range 0.60;3.52). Results adjusted for gender, age, education level, physical activity level, smoking and body mass index.
c MetS: according to the Joint Interim Statement JIS 2009 criterion (18). 
d HOMA-IR: calculated according to Matheus et al. (19), and cut off Geloneze et al. (>2.7) (21). 
(interquartile range 0.60;3.52), and it was 77% higher 
among those with MetS and twice higher among 
those with IR. Except for higher SBP, all other MetS 
components were associated with higher hsCRP. The 
mean VIF ranged between 1.3 and 1.5 in all analyses, 
indicating no multicollinearity between the explanatory 
variables in the final models. 
When the possible moderator role of 25(OH)D was 
investigated, there was evidence of effect modification 
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hsCRP (p-value for interaction 0.03; Figure 2). The 
individuals with normal WC showed similar hsCRP 
median concentrations in all 25(OH)D status (0.96 
mg/L for deficiency, 0.91 mg/L for insufficiency and 
1.10 mg/L for sufficiency). However, the individuals 
with elevated WC and 25(OH)D status of deficiency 
and insufficiency showed hsCRP median concentrations 
2.00 mg/L and 2.14 mg/L respectively, while in 
sufficiency the hsCRP median was 1.57 mg/L.
verified that WC and triglycerides were independently 
associated with hsCRP (β = 0.03 95% IC 0.02;0.03 
and β = 0.21 95%IC 0.10;0.32, respectively) (17). In a 
Japanese prospective study (n = 1,074), the association 
between CRP and IR was less evident among adults 
with normal BMI (β 0.93 95% CI 0.86; 1,00) than 
among those with overweight (β 1.28 95% CI 1.17; 
1,41) or obesity (β 2.13 95% CI 1.98; 2.29) (p-value 
for interaction < 0.001) (18).
However, the relationship between MetS, IR and 
25(OH)D is not consolidated. In a large population-
based cohort with black and white North American 
adults (n = 28,026), 25(OH)D concentration was 
inversely associated with WC (β = -2.3; P < 0.001) 
and IR (β = -0.13; p < 0.001) after adjustment for 
socioeconomic status, history of diabetes, stroke, 
lifestyle habits, the season of the blood draw and 
laboratory parameters (19). Another population-based 
study in the United States (n = 7,674) also verified 
that 25(OH)D sufficiency was associated with 18% 
risk reduction of MetS (prevalence ratio 0.82 95% CI 
0.74-0.91) and 30% risk reduction of IR (prevalence 
ratio = 0.70 95% CI 0.59-0.84) (20). Nonetheless, a 
population-based Iranian study (n = 846) with adults 
verified a null association between MetS and 25(OH)D 
(β = -2.85; p = 0.159), even when the MetS components 
were assessed separately. However, the authors argue 
that the lack of association could be due to the high 
prevalence of hypovitaminosis D in the sample, which 
could interfere with the test power (21). In this study, 
hypertriglyceridemia was associated with lower 25(OH)
D concentrations. Previous studies have suggested 
that this relationship might be explained by increased 
CRP concentrations and abnormal adipocyte function, 
increasing serum concentrations of free fatty acids and 
abdominal obesity (22). However, our results were 
adjusted for BMI, indicating other factors different from 
obesity that would explain the relationship between 
hypertriglyceridemia and 25(OH)D concentrations.
Regarding the moderator role of 25(OH)D in the 
association between elevated WC and hsCRP, some 
hypotheses could explain this finding (16,23-28). 
First, the mechanisms associated with lipogenesis were 
observed in primary-cultured human adipocytes, in 
which 1α25(OH)2D3 exerts an inhibitory effect on 
adipocytes basal lipolysis (23). In male Wistar rats, it 
was also demonstrated that 1α-hydroxylase may have 
a role in the regulation of adipocytes growth and 
metabolism (24).
P-value of the median difference in hsCRP between























Figure 2. Adjusted association between WC and hsCRP, stratified by 
25(OH)D status. Results are adjusted for sex, age, education level, physical 
activity level, smoking, solar radiation level and body mass index. Central 
lines represent the adjusted medians. Lower and upper lines represent the 
adjusted interquartile ranges [p25-p75]. Elevated WC: waist circumference 
> 90 cm in males and > 80 cm in females. 
DISCUSSION
This population-based study conducted in Southern 
Brazil verified that only hypertriglyceridemia and IR 
were associated with lower 25(OH)D concentrations. 
On the other hand, except for higher SBP, all other 
MetS components and IR were associated with higher 
hsCRP concentrations. Nevertheless, hypovitaminosis 
D was an effect modifier of the association between 
elevated WC and hsCRP. 
The relationship between MetS, IR and hsCRP 
is consistent with the available literature (17). A 
population-based Iranian study with 3,285 adults 
showed that higher hsCRP concentrations were 
associated with all components of MetS, except HDL 
(β 0.049; 95% CI -0.050; 0.148) (2). In a Dutch study 
including 1,165 adults with abdominal obesity, a direct 
trend association was observed between the number of 
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In a North American RCT with black adults 
(n = 292), baseline hsCRP adjusted for obesity (BMI 
≥ 30 kg/m²) was inversely associated with baseline 
25(OH)D concentration, which allows inferring 
associations between obesity, inflammation and vitamin 
D status (25). The association of 25(OH)D with WC 
(β = -0.11 95% CI -0.16; -0.06) and hsCRP with WC 
(β 2.40 95% CI 1.71; 3.08) was explored in a North 
American study conducted in a community-based 
sample of adults and older adults (n = 4,010). The 
authors verified that the effect of 25(OH)D on WC was 
mediated by CRP, adiponectin and leptin (mediation 
attributable these mediators = 23%) (19).
According to a meta-analysis with 13 studies, 
supplementation with vitamin D in obese and 
overweight subjects does not have significant changes on 
hsCRP concentrations (standardized mean difference 
-0.11 95% CI -0.27; 0.17) and other inflammatory 
biomarkers, such as tumor necrosis factor-alpha 
(TNF-α) and interleukin 6 (IL-6) (26). 
The modulation role of 25(OH)D in hsCRP was 
discussed in a meta-analysis including 13 studies, in 
which it was demonstrated that supplementation with 
vitamin D is beneficial for reducing hsCRP (standardized 
mean difference -0.45 95% CI -0.77; -0.14) in adults 
and older adult subjects with a diagnosis of diabetes 
mellitus (27). Also, a meta-analysis with 81 clinical trials 
showed a significant reduction in hsCRP (standardized 
mean difference -0.20 95% CI -0.34; -0.06) after a 
minimum of 3 months of vitamin D in adults and older 
adults with different nutrition status BMI (28).
However, it is recommended a careful interpretation 
of 25(OH)D status in inflammatory states. Although 
conducting measurements of serum total 25(OH)
D concentrations is the best way to assess vitamin D 
status in the general population, it might not accurately 
indicate the vitamin D status during illness (29). 
Therefore, the inverse correlation between 25(OH)
D and CRP can be more pronounced in patients 
with inflammatory diseases in comparison to patients 
with non-inflammatory diseases (30). The absence 
of linearity in the associations of CRP and 25(OH)D 
were described in a recent cross-sectional study from 
National Health and Nutrition Examination Survey 
(NHANES). The authors observed that in metabolic 
diseases, specifically in diabetes, the nonlinear 
associations of CRP with 25(OH)D had weakening 
tendency as 25(OH)D increased (31).
Our findings are relevant for public health policies 
among countries facing a rapid increase in the prevalence 
of overweight and non-communicable chronic diseases. 
During the waves of the EpiFloripa study (2009-
2015) the prevalence of overweight among adults in 
Brasil increased from 46.0% to 53.9%, while obesity 
raised from 14.3% to 18.9% (32). As a consequence, 
the main public health policy implemented in Brazil 
during this period was The Strategic Action Plan to 
Tackle Noncommunicable Diseases (NCDs), which 
was launched in 2011 and included strategies to 
monitor these conditions, improve lifestyle, and reduce 
the prevalence and consequences of NCDs (33). Some 
positive signs of change were observed over time, 
including an increase in physical activity levels, fruit and 
vegetable consumption, reduction of the consumption 
of sweet drinks and smoking, while the prevalence 
of obesity, diabetes, and hypertension seems to be 
increasing slowly in the last few years (32). Despite the 
health policies included in The Strategic Action Plan 
to Tackle NCDs, promoting healthy environments and 
obesity reduction are considered a good model, they 
also need to consider activities focused on monitoring 
and treating factors that influence the complex 
pathophysiology linking obesity, inflammation and 
NCDs risk, meeting the principles of synergy and 
interaction (34).
The major strengths of the study are the use of a 
population-based sample from a Latin American country 
and the validated protocols used for data collection. 
Some limitations have to be recognized. First, causal 
inferences are affected by the cross-sectional analysis. 
Second, the use of vitamin D and medications were not 
evaluated in the third wave. However, medications for 
blood glucose control, blood pressure and dyslipidemia 
that characterizes continuous use for blood glucose, 
blood pressure and dyslipidemia control were collected 
in the first wave, and the use of these data minimizes 
possible biases of MetS under diagnosis by JIS 2009 
criteria in the third wave. The use of first wave data 
minimizes possible biases of MetS underdiagnosis 
by JIS 2009 criteria. Third, considering that more 
than 90% of circulating 25(OH)D in human serum 
is protein bound, changes in the vitamin D-binding 
protein and albumin concentrations can alter measured 
total 25(OH)D concentrations without influencing its 
free concentrations (35). Although the albumin serum 
concentrations were not measured in the EpiFloripa 



















Moderator role of vitamin D in metabolic syndrome 
Arch Endocrinol Metab. 2020;64/6
conditions that may influence albumin concentrations 
were excluded from the analyzes to minimize this 
source of bias.
In summary, this study observed an association 
between hypertriglyceridemia and IR with 
25(OH)D and the association between MetS, its 
diagnostic components and IR with hsCRP. The results 
still demonstrated that the association of abdominal 
obesity (evaluated by WC) and inflammation might 
be moderated by vitamin D status. Additionally, these 
findings suggest that 25(OH)D concentrations could be 
incorporated into the clinical protocols for monitoring 
individuals with abdominal obesity to identify those at 
a higher risk of NCDs and their complications.
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